GRACE Risk Score Calculator

GRACE Risk Score Calculator for Cardiology. GRACE outputs a probability, but for NSTE-ACS most clinicians act on band cutoffs. For in-hospital mortality, a score up to about 108 is low risk (under ~1%), 109-140 intermediate (~1-3%), and above 140 high risk (over ~3%); analogous bands (up to ~88, 89-118, over 118) apply to 6-month post-discharge death. The clinically decisive cutoff is 140: crossing it shifts an NSTE-ACS patient from a selective/routine invasive pathway toward early (within 24 h) angiography. A rising or high score should also prompt closer monitoring, uptitration of guideline-directed therapy, and earlier specialist involvement, not merely documentation of a number.

How this calculator works

The GRACE (Global Registry of Acute Coronary Events) Risk Score is a logistic-regression-derived model that converts routine admission variables into an estimated probability of death across the whole acute coronary syndrome (ACS) spectrum — STEMI, NSTEMI, and unstable angina. The original 2003 model used eight weighted predictors: age, heart rate, systolic blood pressure, serum creatinine, Killip class, ST-segment deviation, positive cardiac biomarkers, and cardiac arrest at presentation. The later GRACE model (Fox 2006) added prior heart failure and peripheral vascular disease and extended the endpoint to include the composite of death or myocardial infarction. Points are summed and mapped through a non-linear nomogram (later a continuous algorithm in GRACE 2.0) to a percentage risk rather than a simple additive total, which is why it is normally computed electronically.

When to use this calculator

Use GRACE at first medical contact and again at discharge in any patient with confirmed or suspected ACS to quantify short- and medium-term mortality risk. In NSTE-ACS it is the score the ESC guideline points to for triaging invasive strategy timing: a GRACE score above 140 flags high-risk patients in whom an early invasive angiography (within 24 hours) is favored, whereas lower scores support a selective or delayed approach. It should not be used to diagnose ACS, to assess bleeding risk (use CRUSADE or ARC-HBR for that), or in undifferentiated chest pain where ACS has been ruled out; it also was not derived for out-of-hospital cardiac arrest survivors or type 2 MI, where its calibration is uncertain.

Inputs used

  • Age
  • Heart rate
  • Systolic blood pressure
  • Creatinine
  • Killip class
  • Cardiac arrest
  • ST deviation
  • Cardiac biomarkers

Clinical interpretation

GRACE outputs a probability, but for NSTE-ACS most clinicians act on band cutoffs. For in-hospital mortality, a score up to about 108 is low risk (under ~1%), 109-140 intermediate (~1-3%), and above 140 high risk (over ~3%); analogous bands (up to ~88, 89-118, over 118) apply to 6-month post-discharge death. The clinically decisive cutoff is 140: crossing it shifts an NSTE-ACS patient from a selective/routine invasive pathway toward early (within 24 h) angiography. A rising or high score should also prompt closer monitoring, uptitration of guideline-directed therapy, and earlier specialist involvement, not merely documentation of a number.

Worked example

Consider a 72-year-old NSTEMI patient: heart rate 95/min, systolic BP 130 mmHg, creatinine 1.4 mg/dL (124 micromol/L), Killip class II, ST-segment deviation present, elevated troponin, no cardiac arrest. Age contributes the largest block of points, with additional points for the heart failure signs (Killip II), the renal and biomarker findings, and ST deviation. Summed, this places the patient in a total-score range corresponding to roughly a 12-15% estimated in-hospital mortality and a GRACE score comfortably above the 140 threshold — so this patient is classified high risk and would be prioritized for coronary angiography within 24 hours rather than a delayed strategy.

Limitations and safety notes

GRACE was derived in a registry that under-represented certain groups, so calibration can drift in the very elderly, in advanced chronic kidney disease (where the creatinine term inflates the score), and in populations demographically different from the original 1999-2005 cohorts. It captures no anatomical or angiographic data and says nothing about bleeding risk, so it cannot by itself weigh the net benefit of an invasive strategy. The score also assumes accurate Killip class and reliable troponin/ST interpretation; misclassifying these substantially changes the estimate. Randomized data have not consistently shown that routing patients by a GRACE 140 cutoff improves hard outcomes, so it informs rather than dictates the timing decision.

Frequently asked questions

What is the GRACE score of 140 cutoff used for?

In non-ST-elevation ACS, a GRACE score above 140 identifies high-risk patients for whom current ESC guidance favors an early invasive strategy (angiography within 24 hours). Scores at or below 140 support a more selective or delayed invasive approach based on other risk features.

How does GRACE differ from the TIMI risk score?

TIMI uses seven equally weighted yes/no items and is quicker at the bedside, but GRACE incorporates continuous physiologic variables (heart rate, blood pressure, creatinine, age) and Killip class, giving it stronger discrimination for mortality (c-statistic ~0.83 in derivation). GRACE is generally preferred for mortality risk and invasive-strategy triage.

Why do I need a calculator instead of just adding points?

Unlike a simple additive score, GRACE maps the summed points through a non-linear nomogram (a continuous algorithm in GRACE 2.0) to convert them into an actual mortality probability. That transformation is impractical to do by hand, which is why the score is computed electronically.

Does GRACE tell me the bleeding risk of angiography?

No. GRACE estimates ischemic/mortality risk only. Bleeding risk for an invasive or antithrombotic strategy should be assessed separately, for example with the CRUSADE score or ARC-HBR criteria, and the two are weighed against each other.

When should I calculate GRACE during the admission?

Calculate it at first medical contact to guide early management and invasive-strategy timing, and recalculate at discharge to estimate 6-month post-discharge mortality, which informs intensity of secondary prevention and follow-up.

References

  • Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, Van de Werf F, Avezum A, Goodman SG, Flather MD, Fox KAA. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003. PMID: 14581255.
  • Fox KAA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de Werf F, Avezum A, Goodman SG, Flather MD, Anderson FA, Granger CB. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ. 2006. PMID: 17032691.
  • European Society of Cardiology (Byrne RA, Rossello X, Coughlan JJ, et al.). 2023 ESC Guidelines for the management of acute coronary syndromes. 2023.

Editorial review and citation methodology

Reviewed by the Quick Medical Calculator Editorial Team. Last reviewed: April 5, 2026. The review checks calculator inputs, intended population, interpretation, limitations, and source alignment.

  • Prefer original validation studies for scoring systems and prediction tools.
  • Use current specialty society guidance, transplant allocation policy, public health guidance, or regulator resources when they govern clinical use.
  • Include limitations and safety notes when a calculator is population-specific, context-dependent, or unsuitable as a standalone decision tool.

Related reviewed calculators